Leigh MacConell

Company: HighTide Therapeutics

Job title: Chief Development Officer

Seminars:

Adding a Gut-Liver Targeted Metabolic Modulator Using Novel Inflammatory Pathways for Increased Metabolic Benefits 1:40 pm

Targeting novel inflammatory pathways within the gut-liver axis presents a promising strategy for developing innovative metabolic modulators Leveraging these modulators in combination with existing therapies, such as GLP-1 receptor agonists, to offer enhanced metabolic benefits, including improved weight loss, glycemic control, and reduced hepatic steatosis Providing a treatment with better ease of patient use for…Read more

day: Day One